The Cigna Group
CI: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$322.00 | Cbnmx | Shplrlqq |
Cigna Turns in Strong Q3; Raising Fair Value Estimate on Recent Cash Flows
Narrow-moat Cigna turned in better-than-expected third-quarter operating results that allowed management to boost its 2022 outlook a bit. After incorporating recently generated cash flows (primarily) and mildly stronger recent trends (secondarily), we are raising our fair value estimate in the midsingle digits on a percentage basis. Shares appear about fairly valued, in our opinion.